CLINICAL OUTCOME OF WORLD HEALTH ORGANIZATION GRADE II AND III MENINGIOMAS

被引：0
|
作者：
Moon, J. [1 ]
Kim, E. [1 ]
Chang, J. [1 ]
机构：
[1] Severance Hosp, Seoul, South Korea
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P06.11
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results From a Multicenter, International Cohort Study
    Shepard, Matthew J.
    Xu, Zhiyuan
    Kearns, Kathryn
    Li, Chelsea
    Chatrath, Ajay
    Sheehan, Kimball
    Sheehan, Darrah
    Faramand, Andrew
    Niranjan, Ajay
    Kano, Hideyuki
    Gurewitz, Jason
    Bernstein, Kenneth
    Liscak, Roman
    Guseynova, Khumar
    Grills, Inga S.
    Parzen, Jacob S.
    Cifarelli, Christopher P.
    Rehman, Azeem A.
    Atik, Ahmet
    Bakhsheshian, Joshua
    Zada, Gabriel
    Chang, Eric
    Giannotta, Steven
    Speckter, Herwin
    Wu, Hsiu-Mei
    Kondziolka, Douglas
    Golfinos, John G.
    Mathieu, David
    Lee, Cheng-Chia
    Warnick, Ronald E.
    Lunsford, L. Dade
    Sheehan, Jason P.
    NEUROSURGERY, 2021, 88 (05) : 980 - 988
  • [32] Treatment Decisions of World Health Organization Grade II and III Ependymomas in Molecular Era
    Jung, Tae-Young
    Jung, Shin
    Kook, Hoon
    Baek, Hee-Jo
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2018, 61 (03) : 312 - 318
  • [33] Re: World Health Organisation grade III meningiomas. A retrospective study for outcome and prognostic factors assessment
    Sofela, A.
    NEUROCHIRURGIE, 2021, 67 (02) : 210 - 210
  • [34] Clinical characteristics and management differences for grade II and III spinal meningiomas
    William E. Krauss
    Yagiz Ugur Yolcu
    Mohammed Ali Alvi
    F. M. Moinuddin
    Anshit Goyal
    Michelle J. Clarke
    W. Richard Marsh
    Mohamad Bydon
    Journal of Neuro-Oncology, 2021, 153 : 313 - 320
  • [35] Clinical characteristics and management differences for grade II and III spinal meningiomas
    Krauss, William E.
    Yolcu, Yagiz Ugur
    Alvi, Mohammed Ali
    Moinuddin, F. M.
    Goyal, Anshit
    Clarke, Michelle J.
    Marsh, W. Richard
    Bydon, Mohamad
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (02) : 313 - 320
  • [36] Interferon-α for Recurrent World Health Organization Grade 1 Intracranial Meningiomas
    Chamberlain, Marc C.
    Glantz, Michael J.
    CANCER, 2008, 113 (08) : 2146 - 2151
  • [37] National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas
    Yeboa, Debra Nana
    Liao, Kia-ping
    Guadagnolo, Beverly Ashleigh
    Rao, Ganesh
    Bishop, Andrew
    Chung, Caroline
    Li, Jing
    Tatsui, Claudio Esteves
    Rhines, Laurence D.
    Ferguson, Sherise
    Paulino, Arnold de la Cruz
    Ghia, Amol Jitendra
    WORLD NEUROSURGERY, 2019, 124 : E580 - E594
  • [38] Clinical Efficacy of Adjuvant Radiotherapy for World Health Organization Grade II Intracranial Meningioma
    Palmieri, Mauro
    Armocida, Daniele
    De Pietro, Raffaella
    Chiarello, Giuseppina
    Rizzo, Francesca
    Garbossa, Diego
    Marampon, Francesco
    Santoro, Antonio
    Frati, Alessandro
    WORLD NEUROSURGERY, 2023, 175 : E1117 - E1123
  • [39] Commentary: Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results From a Multicenter, International Cohort Study COMMENT
    Chen, Ching-Jen
    Ding, Dale
    NEUROSURGERY, 2021, 88 (05) : E408 - E409
  • [40] WHO Criteria Act Synergistically to Influence Clinical Outcome in Grade II Meningiomas
    Martin, S. E.
    Wagner, S. A.
    Hattab, E. M.
    MODERN PATHOLOGY, 2014, 27 : 438A - 438A
12345